Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXE5MW
|
||||
Drug Name |
4-[(4-Chlorophenyl)methyl]-2-{2-[[4-(4-{[3-(hexahydro-1Hazepin-1-yl)propyl]oxy}phenyl)butyl](methyl)amino]ethyl}-1(2H)-phthalazinone
|
||||
Synonyms |
CHEMBL1767163
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C37H47ClN4O2
|
||||
Canonical SMILES |
CN(CCCCc1ccc(OCCCN2CCCCCC2)cc1)CCN3N=C(Cc4ccc(Cl)cc4)c5ccccc5C3=O
|
||||
InChI |
InChI=1S/C37H47ClN4O2/c1-40(22-9-6-11-30-16-20-33(21-17-30)44-28-10-25-41-23-7-2-3-8-24-41)26-27-42-37(43)35-13-5-4-12-34(35)36(39-42)29-31-14-18-32(38)19-15-31/h4-5,12-21H,2-3,6-11,22-29H2,1H3
|
||||
InChIKey |
QQERDUJEEYWVED-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
Histamine H1 receptor | Target Info | [1587926] | |||
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.